Genome-wide association studies in type 1 diabetes - Current Diabetes Reports
- ️Hakonarson, Hakon
- ️Sat Mar 21 2009
Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group [no authors listed]. Lancet 2000, 355:873–876.
Onkamo P, Vaananen S, Karvonen M, Tuomilehto J: Worldwide increase in incidence of type I diabetes: the analysis of the data on published incidence trends. Diabetologia 1999, 42:1395–1403.
Bell GI, Horita S, Karam JH: A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984, 33:176–183.
Bennett ST, Lucassen AM, Gough SC, et al.: Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995, 9:284–292.
Vafiadis P, Bennett ST, Todd JA, et al.: Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997, 15:289–292.
Barratt BJ, Payne F, Lowe CE, et al.: Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 2004, 53:1884–1889.
Kristiansen OP, Larsen ZM, Pociot F: CTLA-4 in autoimmune diseases—a general susceptibility gene to autoimmunity? Genes Immun 2000, 1:170–184.
Ueda H, Howson JM, Esposito L, et al.: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506–511.
Anjos SM, Tessier MC, Polychronakos C: Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J Clin Endocrinol Metab 2004, 89:6257–6265.
Nisticò L, Buzzetti R, Pritchard LE, et al.: The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996, 5:1075–1080.
Bottini N, Musumeci L, Alonso A, et al.: A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36:337–338.
Smyth D, Cooper JD, Collins JE, et al.: Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004, 53:3020–3023.
Vella A, Cooper JD, Lowe CE, et al.: Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 2005, 76:773–779.
Qu HQ, Montpetit A, Ge B, et al.: Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 2007, 56:1174–1176.
Lowe CE, Cooper JD, Brusko T, et al.: Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 2007, 39:1074–1082.
Guo D, Li M, Zhang Y, et al.: A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 2004, 36:837–841.
Mirel DB, Valdes AM, Lazzeroni LC, et al.: Association of IL4R haplotypes with type 1 diabetes. Diabetes 2002, 51:3336–3341.
Biason-Lauber A, Boehm B, Lang-Muritano M, et al.: Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 2005, 48:900–905.
The International HapMap Consortium: The International HapMap Project. Nature 2003, 426:789–796.
Smyth DJ, Cooper JD, Bailey R, et al.: A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006, 38:617–619.
Knip M, Veijola R, Virtanen SM, et al.: Environmental triggers and determinants of type 1 diabetes. Diabetes 2005, 54(Suppl 2):S125–S136.
Hakonarson H, Grant SF, Bradfield JP, et al.: A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007, 448:591–594.
Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661–678.
Todd JA, Walker NM, Cooper JD, et al.: Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39:857–864.
Hakonarson H, Qu HQ, Bradfield JP, et al.: A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study. Diabetes 2008, 57:1143–1146.
Nejentsev S, Howson JM, Walker NM, et al.: Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007, 450:887–892.
Grant SF, Qu HQ, Bradfield JP, et al.: Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes 2009, 58:290–295.
Muto A, Hoshino H, Madisen L, et al.: Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3′ enhancer. Embo J 1998, 17:5734–5743.
Concannon P, Onengut-Gumuscu S, Todd JA, et al.: A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes 2008, 57:2858–2861.
Bergholdt R, Eising S, Nerup J, Pociot F: Increased prevalence of Down’s syndrome in individuals with type 1 diabetes in Denmark: a nationwide population-based study. Diabetologia 2006, 49:1179–1182.
Van Goor JC, Massa GG, Hirasing R: Increased incidence and prevalence of diabetes mellitus in Down’s syndrome. Arch Dis Child 1997, 77:186.
Anwar AJ, Walker JD, Frier BM: Type 1 diabetes mellitus and Down’s syndrome: prevalence, management and diabetic complications. Diabet Med 1998, 15:160–163.
Tsygankov AY: Multidomain STS/TULA proteins are novel cellular regulators. IUBMB Life 2008, 60:224–231.
Cohen S, Dadi H, Shaoul E, et al.: Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999, 93:2013–2024.
Cooper JD, Smyth DJ, Smiles AM, et al.: Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 2008, 40:1399–1401.
Mueller PW, Rogus JJ, Cleary PA, et al.: Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol 2006, 17:1782–1790.
GAIN Collaborative Research Group, Manolio TA, Rodriguez LL, et al.: New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat Genet 2007, 39:1045–1051.
Hayashi K, Altman A: Protein kinase C theta (PKCtheta): a key player in T cell life and death. Pharmacol Res 2007, 55:537–544.
Wilkin TJ: The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001, 44:914–922.
Huxtable SJ, Saker PJ, Haddad L, et al.: Analysis of parentoffspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles. Diabetes 2000, 49:126–130.
Grant SF, Thorleifsson G, Reynisdottir I, et al.: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38:320–323.
Qu HQ, Polychronakos C: The TCF7L2 locus and type 1 diabetes. BMC Med Genet 2007, 8:51.
Field SF, Howson JM, Smyth DJ, et al.: Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects. Diabetologia 2007, 50:212–213.
Cervin C, Lyssenko V, Bakhtadze E, et al.: Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 2008, 57:1433–1437.
Qu HQ, Grant SF, Bradfield JP, et al.: Association analysis of type 2 diabetes Loci in type 1 diabetes. Diabetes 2008, 57:1983–1986.
Frayling TM, Timpson NJ, Weedon MN, et al.: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889–894.
Virtanen SM, Knip M: Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr 2003, 78:1053–1067.
Field SF, Howson JM, Walker NM, et al.: Analysis of the obesity gene FTO in 14,803 type 1 diabetes cases and controls. Diabetologia 2007, 50:2218–2220.
Barrett JC, Hansoul S, Nicolae DL, et al.: Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 2008.
International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, et al.: Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007, 357:851–862.